Covid-19 roundup: EMA starts rolling re­view of Rus­si­a's Sput­nik V; No­vavax says shot is 51% ef­fec­tive against vari­ant in South Africa 

The EMA has start­ed a rolling re­view of Sput­nik V, the Russ­ian vac­cine that holds the du­bi­ous ti­tle of the world’s first reg­is­tered jab for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.